|
FAM168A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.31220000000465E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.261430E-03 |
| Normal-vs-Stage2 |
4.482600E-03 |
| Normal-vs-Stage3 |
1.88213999999798E-05 |
| Normal-vs-Stage4 |
8.39960000000861E-05 |
| Stage1-vs-Stage2 |
8.016200E-01 |
| Stage1-vs-Stage3 |
1.443400E-01 |
| Stage1-vs-Stage4 |
2.107800E-01 |
| Stage2-vs-Stage3 |
4.628600E-01 |
| Stage2-vs-Stage4 |
4.001000E-01 |
| Stage3-vs-Stage4 |
7.976600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.585880E-04 |
| Normal-vs-AfricanAmerican |
1.363440E-01 |
| Normal-vs-Asian |
2.281700E-03 |
| Caucasian-vs-AfricanAmerican |
2.969600E-01 |
| Caucasian-vs-Asian |
7.808200E-01 |
| AfricanAmerican-vs-Asian |
2.941800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.99029999994982E-06 |
| Normal-vs-Female |
5.605500E-04 |
| Male-vs-Female |
6.371600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.898200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.13670000000144E-05 |
| Normal-vs-Age(61-80Yrs) |
9.53200000000098E-05 |
| Normal-vs-Age(81-100Yrs) |
6.999300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.131580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.373020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.112400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.454200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.969800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.372000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.649700E-02 |
| Classical-VS-Follicular |
9.575200E-03 |
| Classical-VS-Other |
1.118240E-01 |
| Classical-VS-Normal |
3.255400E-03 |
| Tall-VS-Follicular |
8.980600E-01 |
| Tall-VS-Other |
3.304600E-01 |
| Tall-VS-Normal |
3.171700E-04 |
| Follicular-VS-Other |
4.300800E-01 |
| Follicular-VS-Normal |
3.23020000003726E-06 |
| Other-VS-Normal |
3.981500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.169810E-04 |
| Normal-vs-N1 |
2.388500E-04 |
| N0-vs-N1 |
5.090400E-01 |
|
|
